Literature DB >> 18472865

Insoluble glycogen, a metabolizable internal adsorbent, decreases the lethality of endotoxin shock in rats.

S Sipka1, G Bot, P Gergely, L Bertók, J Csongor, P Sápy, M Szappanos, J Nemes, E Duda, G Szegedi.   

Abstract

Insoluble glycogen is an enzymatically modified form of naturally occurring soluble glycogen with a great adsorbing capacity. It can be metabolized by phagocytes to glucose. In this study we used insoluble glycogen intravenously in the experimental endotoxin shock of rats. Wistar male rats were sensitized to endotoxin by Pb acetate. The survival of rats were compared in groups of animals endotoxin shock treated and non-treated with insoluble glycogen. Furthermore, we have determined in vitro the binding capacity of insoluble glycogen for endotoxin, tumour necrosis factor alpha, interleukin-1 and secretable phospholipase A2. Use of 10 mg/kg dose of insoluble glycogen could completely prevent the lethality of shock induced by LD50 quantity of endotoxin in rats. All animals treated survived. Insoluble glycogen is a form of 'metabolizable internal adsorbents'. It can potentially be used for treatment of septic shock.

Entities:  

Year:  1997        PMID: 18472865      PMCID: PMC2365878          DOI: 10.1080/09629359791442

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  15 in total

1.  New therapeutic method against septic shock--removal of endotoxin using extracorporeal circulation.

Authors:  M Kodama; K Hanasawa; T Tani
Journal:  Adv Exp Med Biol       Date:  1990       Impact factor: 2.622

2.  Protecting effects of intravenous insoluble glycogen treatment on the experimental necrotizing acute pancreatitis of dogs.

Authors:  S Sipka; P Sapy; G Bot; I Furka; I Mikó; P Arkossy; G Dauda; M Szappanos; J Kovacs; G Lakos; G Szegedi
Journal:  Hepatogastroenterology       Date:  1997 Jan-Feb

Review 3.  Molecular basis of activation and regulation of the phagocyte respiratory burst.

Authors:  N P Hurst
Journal:  Ann Rheum Dis       Date:  1987-04       Impact factor: 19.103

4.  Insoluble glycogen and its interaction with phosphorylase. A novel method for the purification of liver phosphorylase A.

Authors:  I Farkas; B Tóth; P Gergely; G Bot
Journal:  Acta Biochim Biophys Hung       Date:  1987

5.  Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone.

Authors:  T W Doebber; M S Wu; J C Robbins; B M Choy; M N Chang; T Y Shen
Journal:  Biochem Biophys Res Commun       Date:  1985-03-29       Impact factor: 3.575

6.  Effect of lead acetate on the susceptibility of rats to bacterial endotoxins.

Authors:  H Selye; B Tuchweber; L Bertók
Journal:  J Bacteriol       Date:  1966-02       Impact factor: 3.490

7.  Potential therapeutic efficacy of inhibitors of human phospholipase A2 in septic shock.

Authors:  P Vadas; E Stefanski; W Pruzanski
Journal:  Agents Actions       Date:  1986-11

8.  Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia.

Authors:  M K Eskandari; G Bolgos; C Miller; D T Nguyen; L E DeForge; D G Remick
Journal:  J Immunol       Date:  1992-05-01       Impact factor: 5.422

9.  Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.

Authors:  J C Mathison; E Wolfson; R J Ulevitch
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

10.  Triglyceride-rich lipoproteins prevent septic death in rats.

Authors:  T E Read; C Grunfeld; Z L Kumwenda; M C Calhoun; J P Kane; K R Feingold; J H Rapp
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.